FOOD
AND DRUG ADMINISTRATION
TRANSMISSIBLE
SPONGIFORM ENCEPHALOPATHIES
ADVISORY COMMITTEE
June 28
& 29, 2001
BRIEFING INFORMATION
FIRST
DAY, Thursday, June 28, 2001, OPEN SESSION
TOPIC 1.
Review of on suitability of blood donors who have lived or traveled in
various countries based on recent information concerning new-variant
Creutzfeldt-Jakob disease (vCJD) and bovine spongiform encephalopathy (BSE)
Guidance for Industry: Revised Precautionary Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and New Variant Creutzfeldt-Jakob Disease (nvCJD) by Blood and Blood Products pdf
TOPIC 2. Safety of FDA-Regulated Plasma Derivatives Prepared in Establishments
Proposing to Use on the Same Manufacturing Line, Plasma Which Does and Plasma
Which Does Not Comply with Potential European Donor Deferrals for vCJD Risk
Factors pdf html